OATP1A/1B Transporters Affect Irinotecan and SN-38 Pharmacokinetics and Carboxylesterase Expression in Knockout and Humanized Transgenic Mice

Dilek Iusuf(Utrecht University), Alfred H. Schinkel(Oncode Institute), Martin van der Valk, Olaf van Tellingen(Dutch Cancer Society), Ahmed M.O. Elbatsh(Oncode Institute), Anita van Esch, Els Wagenaar(The Netherlands Cancer Institute), Fan Lin(University of Chinese Academy of Sciences), Marion Ludwig(The Netherlands Cancer Institute), Evita van de Steeg(Netherlands Organisation for Applied Scientific Research)
Molecular Cancer Therapeutics
November 5, 2013
10.1158/1535-7163.mct-13-0541
Cited by 42

Related Papers

Disruption of the mouse mdr1a P-glycoprotein gene leads to a deficiency in the blood-brain barrier and to increased sensitivity to drugs
|Cell|1994|2.3k
Overcoming the blood–brain tumor barrier for effective glioblastoma treatment
|Drug Resistance Updates|2015|1k
Normal viability and altered pharmacokinetics in mice lacking mdr1-type (drug-transporting) P-glycoproteins
|Proceedings of the National Academy of Sciences|1997|941
Limited oral bioavailability and active epithelial excretion of paclitaxel (Taxol) caused by P-glycoprotein in the intestine
|Proceedings of the National Academy of Sciences|1997|884
Potent and specific inhibition of the breast cancer resistance protein multidrug transporter in vitro and in mouse intestine by a novel analogue of fumitremorgin C.
|PubMed|2002|688